Carl Dambkowski

Director

Carl Dambkowski (Director) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales), most often in Apogee Therapeutics, Inc. (APGE). The largest single filing was $6.2M of ORKA (105,000 sh across 3 lots, as filed), executed May 21.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 14 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$18.5M

shares × price, as filed

Last traded

Aug 5

Filed Aug 7

Median ADV $371.2M across their filed names

Open performance→

Volume by month

Buys $0 Sells $20.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 14 filings

Sector per market data · by filing · past 12 months

Most traded names

APGE

Apogee Therapeutics, Inc. APGE · 0 buys · 21 sells 21 filings ORKA

Oruka Therapeutics, Inc. ORKA · 0 buys · 2 sells 2 filings

Recent filings

APGESALE Apogee Therapeutics, Inc. View filing → $738K
5,500 sh × $134.17
Exec Aug 5
Filed Aug 7 · 8:00 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $730K
5,500 sh × $132.74
Exec Jul 1
Filed Jul 2 · 8:13 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $3.5M
26,400 sh × $132.60
Exec Jun 22
Filed Jun 24 · 5:30 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $2.5M
35,000 sh across 2 lots
Exec Jun 11
Filed Jun 12 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $433K
5,500 sh × $78.71
Exec Jun 3
Filed Jun 5 · 5:30 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $6.2M
105,000 sh across 3 lots
Exec May 21
Filed May 22 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $463K
5,500 sh across 2 lots
Exec May 6
Filed May 8 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $458K
5,400 sh across 2 lots
Exec Apr 1
Filed Apr 3 · 5:30 PM ET More filings →